t(1;7;22)(p13;q21;q13) is a novel 3‑way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

t(1;7;22)(p13;q21;q13) is a novel 3‑way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report

Published:2023-01-31 Issue:3 Volume:18 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Messiaen Julie¹,Uyttebroeck Anne²,Michaux Lucienne³,Vandenberghe Peter³,Boeckx Nancy⁴,Jacobs Sandra²

Affiliation:

1. Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium

2. Department of Pediatric Hematology and Oncology, University Hospitals Leuven, 3000 Leuven, Belgium

3. Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium

4. Laboratory of Clinical Bacteriology and Mycology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference18 articles.

1. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children;Lion;Blood,1992

2. Biology and outcome of childhood acute megakaryoblastic leukemia: A single institution's experience;Athale;Blood,2001

3. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): A study of the Groupe Français de Cytogénétique Hématologique (GFCH);Dastugue;Blood,2002

4. Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: Improved outcome with intensified induction treatment;Reinhardt;Leukemia,2005

5. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: A pediatric oncology group study;Carroll;Blood,1991

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults;Cancers;2024-02-29

2. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216;Blood Advances;2023-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3